Home/Filings/4/0001104659-20-022138
4//SEC Filing

Gionco David 4

Accession 0001104659-20-022138

CIK 0001264587other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 9:28 PM ET

Size

4.8 KB

Accession

0001104659-20-022138

Insider Transaction Report

Form 4
Period: 2020-02-10
Gionco David
Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2020-02-10+107,317342,738 total
Footnotes (2)
  • [F1]The 107,317 shares will vest in three installments as follows: 35,773 shares will vest on January 20, 2021; 35,772 shares will vest on February 16, 2022, and 35,772 shares will vest on March 29, 2023.
  • [F2]Of the shares listed, 287,719 shares are restricted stock.

Documents

1 file

Issuer

STEMLINE THERAPEUTICS INC

CIK 0001264587

Entity typeother

Related Parties

1
  • filerCIK 0001456864

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:28 PM ET
Size
4.8 KB